Cutaneous malignant lymphomas are a heterogeneous group and show an indolent to a very aggressive course. Accordingly, therapeutic goals are various. We reviewed chemotherapies, including CHOP and supportive care, for cutaneous lymphoma based on current evidence. [Skin Cancer (Japan) 2004; 19: 55-63]
